Evidence map›Paper›PMID 38710943›Full record

ArticleNPJ precision oncology2024

Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.

Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris, David Chen, Judit Börcsök, Miklos Diossy, Viktoria Tisza, Sandor Spisak and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ precision oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Aurel Prosz *Danish Cancer Institute, Copenhagen, Denmark.
Pranshu Sahgal *Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9857-3987
Brandon M HuffmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0768-3145
Zsofia SztupinszkiDanish Cancer Institute, Copenhagen, Denmark.
Clare X MorrisDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
David ChenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Judit BörcsökDanish Cancer Institute, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-3290-3971
Miklos DiossyDanish Cancer Institute, Copenhagen, Denmark.
Viktoria TiszaInstitute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
Sandor SpisakInstitute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
Pornlada LikasitwatanakulDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Orsolya Rusz2nd Department of Pathology, SE NAP, Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary.
Istvan CsabaiDepartment of Physics of Complex Systems, Eötvös Loránd University, Budapest, Hungary.ORCID http://orcid.org/0000-0001-9232-9898
Michael CecchiniDepartment of Medical Oncology, Center for Gastrointestinal Cancers, Yale Medical Center, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3504-0128
Yasmine BacaCaris Life Sciences, Phoenix, AZ, USA.
Andrew ElliottCaris Life Sciences, Phoenix, AZ, USA.
Peter EnzingerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Harshabad SinghDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jessalyn UbellakerDepartment of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Jean-Bernard LazaroDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James M ClearyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zoltan SzallasiDanish Cancer Institute, Copenhagen, Denmark. Zoltan.szallasi@childrens.harvard.edu.
Nilay S SethiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. nilay_sethi@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-3748-7559

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38710943
PMCPMC11074298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.